266 related articles for article (PubMed ID: 28035784)
1. Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization.
Qian Z; Rhodes CA; McCroskey LC; Wen J; Appiah-Kubi G; Wang DJ; Guttridge DC; Pei D
Angew Chem Int Ed Engl; 2017 Feb; 56(6):1525-1529. PubMed ID: 28035784
[TBL] [Abstract][Full Text] [Related]
2. Designing Cell-Permeable Macrocyclic Peptides.
Appiah Kubi G; Dougherty PG; Pei D
Methods Mol Biol; 2019; 2001():41-59. PubMed ID: 31134566
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a Direct Ras Inhibitor by Screening a Combinatorial Library of Cell-Permeable Bicyclic Peptides.
Trinh TB; Upadhyaya P; Qian Z; Pei D
ACS Comb Sci; 2016 Jan; 18(1):75-85. PubMed ID: 26645887
[TBL] [Abstract][Full Text] [Related]
4. Cell-Permeable Bicyclic Peptidyl Inhibitors against NEMO-IκB Kinase Interaction Directly from a Combinatorial Library.
Rhodes CA; Dougherty PG; Cooper JK; Qian Z; Lindert S; Wang QE; Pei D
J Am Chem Soc; 2018 Sep; 140(38):12102-12110. PubMed ID: 30176143
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the Cell Permeability of Stapled Peptides with a Cyclic Cell-Penetrating Peptide.
Dougherty PG; Wen J; Pan X; Koley A; Ren JG; Sahni A; Basu R; Salim H; Appiah Kubi G; Qian Z; Pei D
J Med Chem; 2019 Nov; 62(22):10098-10107. PubMed ID: 31657556
[TBL] [Abstract][Full Text] [Related]
6. Rational design of cell-permeable cyclic peptides containing a d-Pro-l-Pro motif.
Wen J; Liao H; Stachowski K; Hempfling JP; Qian Z; Yuan C; Foster MP; Pei D
Bioorg Med Chem; 2020 Oct; 28(20):115711. PubMed ID: 33069067
[TBL] [Abstract][Full Text] [Related]
7. Cell-permeable bicyclic peptide inhibitors against intracellular proteins.
Lian W; Jiang B; Qian Z; Pei D
J Am Chem Soc; 2014 Jul; 136(28):9830-3. PubMed ID: 24972263
[TBL] [Abstract][Full Text] [Related]
8. Exploration of the design principles of a cell-penetrating bicylic peptide scaffold.
Wallbrecher R; Depré L; Verdurmen WP; Bovée-Geurts PH; van Duinkerken RH; Zekveld MJ; Timmerman P; Brock R
Bioconjug Chem; 2014 May; 25(5):955-64. PubMed ID: 24697151
[TBL] [Abstract][Full Text] [Related]
9. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
Park SE; Sajid MI; Parang K; Tiwari RK
Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
[TBL] [Abstract][Full Text] [Related]
10. Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.
D'Souza C; Henriques ST; Wang CK; Craik DJ
Eur J Med Chem; 2014 Dec; 88():10-8. PubMed ID: 24985034
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Mechanism of Highly Efficient Cyclic Cell-Penetrating Peptides.
Qian Z; Martyna A; Hard RL; Wang J; Appiah-Kubi G; Coss C; Phelps MA; Rossman JS; Pei D
Biochemistry; 2016 May; 55(18):2601-12. PubMed ID: 27089101
[TBL] [Abstract][Full Text] [Related]
12. Generation of a cell-permeable cycloheptapeptidyl inhibitor against the peptidyl-prolyl isomerase Pin1.
Bedewy W; Liao H; Abou-Taleb NA; Hammad SF; Nasr T; Pei D
Org Biomol Chem; 2017 May; 15(21):4540-4543. PubMed ID: 28517007
[TBL] [Abstract][Full Text] [Related]
13. Effects of linker sequence modifications on the structure, stability, and biological activity of a cyclic α-conotoxin.
Carstens BB; Swedberg J; Berecki G; Adams DJ; Craik DJ; Clark RJ
Biopolymers; 2016 Nov; 106(6):864-875. PubMed ID: 27038328
[TBL] [Abstract][Full Text] [Related]
14. α/β-Peptide Foldamers Targeting Intracellular Protein-Protein Interactions with Activity in Living Cells.
Checco JW; Lee EF; Evangelista M; Sleebs NJ; Rogers K; Pettikiriarachchi A; Kershaw NJ; Eddinger GA; Belair DG; Wilson JL; Eller CH; Raines RT; Murphy WL; Smith BJ; Gellman SH; Fairlie WD
J Am Chem Soc; 2015 Sep; 137(35):11365-75. PubMed ID: 26317395
[TBL] [Abstract][Full Text] [Related]
15. Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity.
Qian Z; Xu X; Amacher JF; Madden DR; Cormet-Boyaka E; Pei D
Angew Chem Int Ed Engl; 2015 May; 54(20):5874-8. PubMed ID: 25785567
[TBL] [Abstract][Full Text] [Related]
16. Perfluoroaryl Bicyclic Cell-Penetrating Peptides for Delivery of Antisense Oligonucleotides.
Wolfe JM; Fadzen CM; Holden RL; Yao M; Hanson GJ; Pentelute BL
Angew Chem Int Ed Engl; 2018 Apr; 57(17):4756-4759. PubMed ID: 29479836
[TBL] [Abstract][Full Text] [Related]
17. NanoClick: A High Throughput, Target-Agnostic Peptide Cell Permeability Assay.
Peier A; Ge L; Boyer N; Frost J; Duggal R; Biswas K; Edmondson S; Hermes JD; Yan L; Zimprich C; Sadruddin A; Kristal Kaan HY; Chandramohan A; Brown CJ; Thean D; Lee XE; Yuen TY; Ferrer-Gago FJ; Johannes CW; Lane DP; Sherborne B; Corona C; Robers MB; Sawyer TK; Partridge AW
ACS Chem Biol; 2021 Feb; 16(2):293-309. PubMed ID: 33539064
[TBL] [Abstract][Full Text] [Related]
18. Nano-Inspired Technologies for Peptide Delivery.
Covarrubias-Zambrano O; Yu J; Bossmann SH
Curr Protein Pept Sci; 2020; 21(4):379-400. PubMed ID: 31793426
[TBL] [Abstract][Full Text] [Related]
19. Phage selection of cyclic peptide antagonists with increased stability toward intestinal proteases.
Baeriswyl V; Heinis C
Protein Eng Des Sel; 2013 Jan; 26(1):81-9. PubMed ID: 23100545
[TBL] [Abstract][Full Text] [Related]
20. Cell-permeable bicyclic peptidyl inhibitors against T-cell protein tyrosine phosphatase from a combinatorial library.
Liao H; Pei D
Org Biomol Chem; 2017 Nov; 15(45):9595-9598. PubMed ID: 29116277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
